Korsana Biosciences, Inc. cotiza a 34.04 USD y tiene una capitalización bursátil de $1.6B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases. The company has developed Therapeutic Targeting (THETA), a blood-brain barrier-penetrant shuttle platform designed to enhance central nervous system exposure of investigational therapies and enable delivery of lar…
| Métrica | KRSA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -239.8% | -38.6% | -201.2% |
| Net Margin | -170.1% | -33.6% | -136.6% |
| FCF Margin | — | -13.9% | — |
| ROE | -38.8% | -40.4% | +1.6% |
| ROA | -35.3% | -32.0% | -3.3% |
| Current Ratio | 5.15 | 2.84 | +2.31 |
| Debt / Equity | — | 0.28 | — |